BDBM50065280 3-[1-(4-Morpholin-4-yl-phenyl)-meth-(Z)-ylidene]-1,3-dihydro-indol-2-one::CHEMBL86480

SMILES O=C1Nc2ccccc2\C1=C\c1ccc(cc1)N1CCOCC1

InChI Key InChIKey=FWFISWZSIAJQSO-UHFFFAOYSA-N

Data  5 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 5 hits for monomerid = 50065280   

TargetInsulin-like growth factor 1 receptor(Human)
Sugen

Curated by ChEMBL
LigandPNGBDBM50065280(3-[1-(4-Morpholin-4-yl-phenyl)-meth-(Z)-ylidene]-1...)
Affinity DataIC50: 1.00E+5nMAssay Description:Concentration required to achieve 50% inhibition of tyrosine phosphorylation on human Insulin-like growth factor I receptorMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
LigandPNGBDBM50065280(3-[1-(4-Morpholin-4-yl-phenyl)-meth-(Z)-ylidene]-1...)
Affinity DataIC50: 2.50E+3nMAssay Description:Concentration required to achieve 50% inhibition of tyrosine phosphorylation on murine VEGF receptor (FLK-1 RTK).More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
LigandPNGBDBM50065280(3-[1-(4-Morpholin-4-yl-phenyl)-meth-(Z)-ylidene]-1...)
Affinity DataIC50: 1.00E+5nMAssay Description:Concentration required to achieve 50% inhibition of tyrosine phosphorylation on human Her-2 receptor tyrosine kinase (HER-2 RTK)More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetEpidermal growth factor receptor(Human)
Sugen

Curated by ChEMBL
LigandPNGBDBM50065280(3-[1-(4-Morpholin-4-yl-phenyl)-meth-(Z)-ylidene]-1...)
Affinity DataIC50: 1.00E+5nMAssay Description:Concentration required to achieve 50% inhibition of tyrosine phosphorylation on human Epidermal growth factor receptor (EGF RTK).More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
LigandPNGBDBM50065280(3-[1-(4-Morpholin-4-yl-phenyl)-meth-(Z)-ylidene]-1...)
Affinity DataIC50: 3.31E+4nMAssay Description:Test concentration required to achieve 50% inhibition of tyrosine phosphorylation on human Platelet-derived growth factor receptor beta (PDGF RTK).More data for this Ligand-Target Pair
In DepthDetails Article
PubMed